Oculometric biomarkers of visuomotor deficits in clinically asymptomatic patients with systemic lupus erythematosus undergoing long-term hydroxychloroquine treatment

MLA

Andrew R. Berneshawi, et al. “Oculometric Biomarkers of Visuomotor Deficits in Clinically Asymptomatic Patients with Systemic Lupus Erythematosus Undergoing Long-Term Hydroxychloroquine Treatment.” Frontiers in Ophthalmology, vol. 4, July 2024. EBSCOhost, https://doi.org/10.3389/fopht.2024.1354892.

APA

Andrew R. Berneshawi, Kimia Seyedmadani, Rahul Goel, Mark R. Anderson, Terence L. Tyson, Yasmin M. Akay, Metin Akay, Loh-Shan B. Leung, & Leland S. Stone. (2024). Oculometric biomarkers of visuomotor deficits in clinically asymptomatic patients with systemic lupus erythematosus undergoing long-term hydroxychloroquine treatment. Frontiers in Ophthalmology, 4. https://doi.org/10.3389/fopht.2024.1354892

Chicago

Andrew R. Berneshawi, Kimia Seyedmadani, Rahul Goel, Mark R. Anderson, Terence L. Tyson, Yasmin M. Akay, Metin Akay, Loh-Shan B. Leung, and Leland S. Stone. 2024. “Oculometric Biomarkers of Visuomotor Deficits in Clinically Asymptomatic Patients with Systemic Lupus Erythematosus Undergoing Long-Term Hydroxychloroquine Treatment.” Frontiers in Ophthalmology 4 (July). doi:10.3389/fopht.2024.1354892.